10times
16 Jun 2021 • 

Combining AI and Automation in the SynFini Platform to Accelerate Small Molecule Drug Discovery

AboutSpeakersExhibitorsReviewsPhotos

Official Links

Estimated Turnout

upto 100
Delegates

Editions

Jun 2021

Frequency

Newly Listed
Claim event to edit details

In an effort to improve and accelerate the reproducibility and transferability of chemistry, we have developed an automation platform named .. Read more SynFini™ that automates the design, reaction screening and optimization (RSO), and production of target molecules. Routes to target molecules are built by combining knowledge of known chemistry from reaction databases and new reactions predicted by machine learning. Automated analysis of the RSO results facilitates the preparation of digital synthesis protocols that can be downloaded to a bench top multistep synthesizer, called AutoSyn. AutoSyn is a flow chemistry workstation capable of performing synthesis routes at the milligram to gram scale while automatically capturing all synthesis parameters in real-time into a new automated chemistry reaction database. To accelerate multi-parametric optimization in drug discovery, artificial intelligence (AI) can be included to aid in the design, selection and prioritization of target structures with desired properties, such as biological activity and ADMET properties, and can be interfaced with SynFini automated synthesis and bioassay testing for rapid ‘design-make-test’ cycles. The original site for employees in the pharma, medical, diagnostic and related industries. Join thousands of other professionals from life science, medical device and food industries.

Anjani Janyavula

Anjani Janyavula

Student at Vellore Institute Of Technology

Chennai, India
  • Share your Experience
  • Organizer
LogoRequest a Booth

Xtalks

Canada463 Total Events / 19 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results